Bile Acid Receptor (NR1H4) Antibody

Este producto es parte de NR1H - nuclear receptor subfamily 1 group H member
Product Graph
351€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Bile Acid Receptor (NR1H4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx376011
tested applications
ELISA, WB

Description

Bile Acid Receptor (NR1H4) Antibody is a Rabbit Polyclonal antibody against Bile Acid Receptor (NR1H4).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetBile Acid Receptor (NR1H4)
HostRabbit
ReactivityHuman, Mouse, Rat
Recommended DilutionOptimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
PurificationPurified by affinity chromatography using epitope-specific immunogen.
Size 1100 µg
FormLiquid
Tested ApplicationsELISA, WB
BufferPBS, pH 7.4, containing 0.02% sodium azide and 50% glycerol.
AvailabilityShipped within 5-12 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDQ96RI1
Gene ID9971
AliasBAR,FXR,HRR1,HRR-1,PFIC5,RIP14,Bile acid receptor,Farnesoid X-activated receptor,Nuclear receptor subfamily 1 group H member 4
BackgroundAntibody anti-NR1H4
StatusRUO
NoteConcentration: 1 mg/ml -

Descripción

Nuclear receptor subfamily 1 group H member 4 (NR1H4), also known as FXR (farnesoid X receptor), is a nuclear receptor that plays a crucial role in regulating bile acid metabolism, liver function, and glucose homeostasis NR1H4 is expressed primarily in the liver, intestine, and kidneys, where it regulates the synthesis, transport, and catabolism of bile acids, which are essential for digestion and the absorption of fats FXR also influences lipid and glucose metabolism, helping maintain energy balance and insulin sensitivity in the liver and other metabolic tissues It plays a key role in protecting the liver from bile acid toxicity by regulating the expression of genes involved in bile acid homeostasis Dysregulation of FXR signaling has been associated with liver diseases such as non-alcoholic fatty liver disease (NAFLD), cirrhosis, and cholestasis, as well as metabolic diseases like obesity and diabetes FXR has emerged as a therapeutic target for managing liver diseases, metabolic syndrome, and conditions related to bile acid imbalances, making it an important receptor for drug development in these areas

Related Products

EH2066

Human NR1H4(Bile acid receptor) ELISA Kit

Ver Producto
abx005908

Bile Acid Receptor (NR1H4) Antibody

NR1H4 Antibody is a Rabbit Polyclonal Antibody against NR1H4.

Ver Producto
abx151489

Human Bile Acid Receptor (NR1H4) ELISA Kit

Human Bile Acid Receptor (NR1H4) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Bile Acid Receptor (NR1H4) concentrations in tissue homogenates, cell lysates and other biological fluids. This assay has high sensitivity and excellent specificity for detection of Farnesoid X Receptor (FXR)

Ver Producto